Spiral Capital

Spiral Capital operates from Tokyo as a forward-thinking venture firm with a notable bias toward deep tech commercialization, including robotics and AI systems designed to address healthcare workforce shortages. The healthcare focus concentrates on AI/ML applications and medical devices and medtech, reflecting the firm’s interest in technologies that can structurally change how care is delivered in aging societies.

The thesis is grounded in a structural observation about Japan and other developed economies: aging populations and healthcare workforce shortages create durable demand for technologies that automate, augment, or replace clinical and operational workflows. Spiral positions itself as the investor underwriting that demand at the deep tech and applied AI level, with portfolio companies that include robotics, automation, and AI-driven workflow systems. Healthcare investments under this thesis are typically technically deep, often involving novel hardware-software combinations, and tend to have a clear articulation of which workforce or operational problem they are solving.

The firm writes checks generally between $1M and $5M, operating at Series A, Series B, and Series C. That stage focus means Spiral expects companies to have working technology and at least early commercial validation by the time a check is written, with diligence calibrated to the technical and commercial maturity expected at these stages. Geographically, the firm is anchored in Japan with selective participation in companies operating internationally, particularly those addressing healthcare workforce challenges in markets with similar demographic pressures.

The partnership is structured with a focus on deep tech and applied AI, and the team has technical depth that supports substantive engagement during diligence. Founders should expect technical questions that engage with the substance of the technology rather than only with commercial metrics, which is generally welcome for founders building genuinely novel hardware-software systems. The team has experience supporting deep tech companies through complex commercialization arcs.

In working with companies, Spiral’s most distinctive value is its connections into the Japanese corporate and healthcare provider ecosystem, which provides early commercial signal and partnership opportunities for healthcare deep tech companies. The firm helps with growth-stage hiring, structuring follow-on rounds, and navigating the operational realities of selling deep tech into Japanese healthcare buyers. For healthcare founders, the fit is strongest for those building deep tech, robotics, or AI-driven workflow systems addressing structural workforce or operational challenges in healthcare. The fit is weaker for purely software digital health companies or for biotech businesses without a clear deep tech dimension, since the firm’s expertise sits at the intersection of hardware, software, and applied AI. Founders considering Spiral should plan for substantive technical conversations during diligence and should welcome an investor focused on the long-term commercialization arc of deep tech systems.